Ascorbic acid promotes prostanoid release in human lung parenchyma

Area of Science:

• Pulmonary Pharmacology
• Biochemistry

Background:

• Ascorbic acid (vitamin C) is known to reduce airway reactivity in humans and guinea pigs.
• The exact mechanism behind this effect is not fully understood, but indomethacin (a cyclooxygenase inhibitor) reverses it.
• This suggests a potential role for prostanoids, which are products of the cyclooxygenase pathway.

Purpose of the Study:

• To investigate whether ascorbic acid influences the synthesis or degradation of prostanoids in human lung tissue.
• To explore the concentration-dependent effects of ascorbic acid on prostanoid generation.

Main Methods:

• Human lung parenchymal slices were incubated with varying concentrations of sodium ascorbate, methacholine, and indomethacin.
• Prostanoid levels (PGE2, PGF2 alpha, thromboxane B2, 6-keto-PGF1 alpha) in the incubation medium were measured using radioimmunoassay.

Main Results:

• Ascorbic acid significantly increased the accumulation of all four measured prostanoids in the incubation medium.
• The stimulatory effect of ascorbic acid on prostanoid generation was dose-dependent.
• Indomethacin inhibited the prostanoid-increasing effect of ascorbic acid.

Conclusions:

• Ascorbic acid modulates prostanoid generation in human lung tissue.
• This alteration in prostanoid synthesis may contribute to the observed antibronchoconstrictor effects of ascorbic acid in humans.